Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

An acute bout of 4 x 4-min or 10 x 1-min HIIT improves beta cell glucose sensitivity in postmenopausal females with type 2 diabetes: a secondary analysis [with consumer summary]
Low JL, Marcotte-Chenard A, Tremblay R, Islam H, Falkenhain K, Mampuya WM, Mari A, McManus AM, Riesco E, Little JP
Journal of Applied Physiology 2025 Jan;138(1):311-317
clinical trial
This trial has not yet been rated.

Improvements in glycemic control following acute exercise are typically attributed to improved postexercise insulin sensitivity (IS) with comparatively little known about how acute exercise impacts beta cell function, especially in postmenopausal females. We determined how two high-intensity interval training (HIIT) protocols, matched for total estimated energy expenditure, impact beta cell function in postmenopausal females with type 2 diabetes. Thirteen postmenopausal females (70 +/- 5 yr; 12 +/- 7 yr since diagnosis, 80.9 +/- 13.8 kg, 32.4 +/- 5.6 kg m 2; HbA1c -49.8 +/- 10.3 mmol/mol (6.7 +/- 1.0)) living with type 2 diabetes were included in this semirandomized crossover trial. The trial involved an initial resting control condition followed by two HIIT conditions (4 x 4-min HIIT (HIIT4) and 10 x 1-min HIIT (HIIT10)) completed in a randomized order 2 to 4 days apart. beta cell function (glucose sensitivity) and insulin sensitivity were determined from a 2-h mixed-meal tolerance test performed 2 h after rest or HIIT. Both HIIT4 and HIIT10 significantly improved beta cell glucose sensitivity compared with control (15 pmol/min/m 2 / (mmol/L), (95% confidence interval (CI) 6 to 23); p = 0.002 and 16 pmol/min/m 2 / (mmol/L), (95% CI 7 to 25); p = 0.002, respectively), with no difference between HIIT protocols (1 (-8 to 10), p = 0.79). There were no significant differences in IS metrics (Matsuda index, OGIS, Stumvoli, and QUICKI) between the conditions. An acute bout of 4 x 4-min or 10 x 1-min HIIT improves beta cell glucose sensitivity in postmenopausal females living with type 2 diabetes. ClinicalTrials.gov: NCT04986345.

Full text (sometimes free) may be available at these link(s):      help